Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PIPELINE ANALYSIS
4.2 PESTEL ANALYSIS
4.3 PORTER'S FIVE FORCES MODEL
5 REGULATORY FRAMEWORK: MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
5.1 REGULATORY SCENARIO IN THE U.S.
5.2 REGULATORY SCENARIO IN THE U.K.
5.3 REGULATORY SCENARIO IN INDIA
5.4 REGULATORY SCENARIO IN UAE
5.5 REGULATORY SCENARIO IN AFRICA
5.6 REGULATORY SCENARIO IN BRAZIL
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS TO TREAT DEPRESSION
6.1.2 INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
6.1.3 RISING AWARENESS TOWARD MENTAL HEALTH
6.1.4 ONGOING CLINICAL TRIALS
6.1.5 RISE IN PRODUCT APPROVALS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
6.2.2 HIGH COST OF PSYCHEDELIC DRUGS
6.2.3 PATENT EXPIRY OF PSYCHEDELIC DRUGS
6.3 OPPORTUNITIES
6.3.1 INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
6.3.2 BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
6.3.3 UPCOMING REHABILITATION CENTERS
6.3.4 AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
6.4 CHALLENGES
6.4.1 SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
6.4.2 RISE IN ILLEGAL ALTERNATIVES
6.4.3 AVAILABILITY OF OTHER TREATMENT OPTIONS
7 COVID-19 IMPACT ON THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE
8.1 OVERVIEW
8.2 EMPATHOGENS
8.3 DISSOCIATIVES
8.4 OTHERS
9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE
9.1 OVERVIEW
9.2 SYNTHETIC
9.3 NATURAL
10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS
10.1 OVERVIEW
10.2 GAMMA-HYDROXYBUTYRIC ACID
10.3 KETAMINE
10.4 PSILOCYBIN
10.5 OTHERS
11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 NARCOLEPSY
11.3 TREATMENT RESISTANT DEPRESSION
11.4 MAJOR DEPRESSIVE DISORDER
11.5 OPIATE ADDICTION
11.6 POST-TRAUMATIC STRESS DISORDER
11.7 OTHERS
12 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 ORAL
12.3 INHALATION
12.4 INJECTABLE
13 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 SPECIALTY CLINICS
13.4 HOMECARE
13.5 OTHERS
14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 HOSPITALS PHARMACY
14.3 RETAIL PHARMACY
14.4 ONLINE PHARMACY
15 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY REGION
15.1 MIDDLE EAST & AFRICA
15.1.1 SAUDI ARABIA
15.1.2 ISRAEL
15.1.3 EGYPT
15.1.4 UAE
15.1.5 SOUTH AFRICA
16 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 JAZZ PHARMACEUTICALS, INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 PFIZER INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 F. HOFFMANN- LA ROCHE LTD
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 JANSSEN MIDDLE EAST & AFRICA SERVICES, LLC (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENT
18.5 AVADEL
18.5.1 COMPANY SNAPSHOT
18.5.2 PRODUCT PORTFOLIO
18.5.3 RECENT DEVELOPMENT
18.6 CELON PHARMA SA
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 COMPASS
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 CYBIN CORP.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 ENTHEON BIOMEDICAL CORP
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 GH RESEARCH
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 HIKMA PHARMACEUTICALS PLC
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 NRX PHARMACEUTICALS, INC.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 PHARMATHER HOLDINGS LTD.
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 VERRIAN
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 USONAINSTITUTE.ORG
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS
TABLE 2 PSYCHEDELICS RESEARCH STUDIES, IN EUROPE
TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020
TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020
TABLE 5 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS
TABLE 6 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES
TABLE 7 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.
TABLE 8 COST OF PSYCHEDELIC DRUGS
TABLE 9 PSYCHEDELIC DRUGS R&D ACTIVITIES
TABLE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 50 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 51 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 52 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 53 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 54 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 55 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 59 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 60 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 61 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 62 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 63 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 64 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 65 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 66 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 67 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 69 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 71 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 72 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 73 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 74 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 76 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 78 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)
TABLE 81 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 82 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)
TABLE 83 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 84 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 RISING AWARENESS TOWARDS MERANTAL HEALTH DRIVING THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 EMPATHOGENS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET
FIGURE 16 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS
FIGURE 17 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY DEMOGRAPHIC GROUPS
FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2020, (IN %), BY GENDER
FIGURE 19 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2021
FIGURE 20 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2021
FIGURE 24 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, 2022-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2021
FIGURE 28 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, 2022-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DRUGS, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2021
FIGURE 32 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 36 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 39 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2021
FIGURE 40 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 41 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2021)
FIGURE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021)
FIGURE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 50 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 51 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY TYPE (2022-2029)
FIGURE 52 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: COMPANY SHARE 2021 (%)
